Bill
HR 1562
The Test Strip Access Act mandates insurance coverage for diabetes test strips, ensuring affordability and availability, improving health outcomes for patients.
The Test Strip Access Act of 2025 aims to improve access to diabetes test strips for individuals with diabetes. The bill seeks to address barriers that patients face in obtaining these essential medical supplies, which are crucial for managing blood glucose levels and preventing complications associated with diabetes.
The bill includes several significant provisions designed to enhance access to test strips:
Insurance Coverage Requirements: The legislation mandates that private health insurance plans and Medicare must cover the cost of diabetes test strips without imposing excessive cost-sharing requirements on patients.
Increased Availability: The bill encourages pharmacies and healthcare providers to ensure a steady supply of test strips, particularly in underserved areas where access may be limited.
Patient Education Programs: It proposes funding for educational initiatives aimed at informing patients about the importance of regular blood glucose monitoring and how to effectively use test strips.
Regulatory Oversight: The bill calls for the Department of Health and Human Services (HHS) to monitor the availability and pricing of test strips to prevent price gouging and ensure affordability.
The primary beneficiaries of the Test Strip Access Act would include:
Individuals with Diabetes: Patients who require regular monitoring of their blood glucose levels will have improved access to necessary test strips, leading to better health outcomes.
Healthcare Providers: Doctors and diabetes educators will have the resources to provide better care and support for their patients.
Pharmacies: Local pharmacies may see an increase in demand for test strips, necessitating better inventory management and supply chain practices.
Introduced Date: The bill was introduced in the House on February 25, 2025.
Committee Referral: Following its introduction, HR 1562 was referred to the House Committee on Energy and Commerce for further consideration.
Sponsorship: The bill is primarily sponsored by Jasmine Crockett, with Lance Gooden serving as a cosponsor, indicating bipartisan support for the initiative.
The Test Strip Access Act of 2025 represents a significant step towards improving healthcare access for individuals with diabetes. By ensuring that test strips are covered by insurance and readily available, the bill aims to enhance the quality of life for patients and reduce the long-term healthcare costs associated with diabetes complications. As the bill progresses through legislative channels, its impact on public health and patient care will be closely monitored.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
